American Oriental Bioengineering (广西博科药业) reported it has SFDA approval to produce 61 of the products included in China's newly announced Essential Drug List, though the company is currently producing only six of them. American Oriental markets 60 pharmaceutical products, and it has another 400 products that have been approved by the SFDA, but aren’t being produced at this point. More details...

Stock Symbol: (NYSE: AOB)